Added to YB: 2026-10-08
Pitch date: 2026-10-04
PAR.AX [bearish]
Paradigm Biopharmaceuticals Limited
Author Info
Equities Club is a team passionate about small-cap mining stocks on the ASX. We tap into an experienced network we’ve built over decades in the mining industry, from geologists, project managers, lawyers, and people in the field, when assessing companies. Sign up for the newsletter.
Company Info
Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia.
Market Cap
AUD 146.8M
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.27
P/E
-1.61
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
A Coles Bowl, a $44 Billion Float and a Drone Maker Back at Work - Paradigm Biopharmaceuticals Limited
PAR.AX (update): Paradigm Biopharmaceuticals has entered administration after its 538-patient Zilosul knee-osteoarthritis trial was stopped at the halfway point because early results were insufficient to continue. The company cannot meet its short-term obligations, directors’ powers are suspended and shareholders rank behind all creditors. Shares remain suspended at 24c; the board is pursuing a deed of company arrangement in a process expected to take at least eight weeks.
Read full article (1 min)